Trial Outcomes & Findings for Analgetic and Anxiolytic Effect of Preoperative Pregabalin (NCT NCT00353704)

NCT ID: NCT00353704

Last Updated: 2011-07-20

Results Overview

The visual analogue scale (VAS) was used for registration of the pain intensity at rest. The score ranges from 0-100, where 0 means no pain and 100 means maximal pain. Higher values represent a worse outcome.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

50 participants

Primary outcome timeframe

120 minutes after surgery

Results posted on

2011-07-20

Participant Flow

recruitment period november 2005 until june 2008

Participant milestones

Participant milestones
Measure
Pregabalin
Placebo
Overall Study
STARTED
25
25
Overall Study
COMPLETED
22
24
Overall Study
NOT COMPLETED
3
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Pregabalin
Placebo
Overall Study
Protocol Violation
3
1

Baseline Characteristics

Analgetic and Anxiolytic Effect of Preoperative Pregabalin

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Pregabalin
n=25 Participants
Placebo
n=25 Participants
Total
n=50 Participants
Total of all reporting groups
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
25 Participants
n=5 Participants
25 Participants
n=7 Participants
50 Participants
n=5 Participants
Age Continuous
44 years
STANDARD_DEVIATION 11 • n=5 Participants
43 years
STANDARD_DEVIATION 8 • n=7 Participants
43 years
STANDARD_DEVIATION 10 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
12 Participants
n=7 Participants
24 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
13 Participants
n=7 Participants
26 Participants
n=5 Participants
Region of Enrollment
Norway
25 participants
n=5 Participants
25 participants
n=7 Participants
50 participants
n=5 Participants

PRIMARY outcome

Timeframe: 120 minutes after surgery

The visual analogue scale (VAS) was used for registration of the pain intensity at rest. The score ranges from 0-100, where 0 means no pain and 100 means maximal pain. Higher values represent a worse outcome.

Outcome measures

Outcome measures
Measure
Pregabalin
n=22 Participants
Placebo
n=24 Participants
Mean VAS Pain (Visual Analogue Scale)at Rest (0-100 mm)
11.7 Units on a scale
Standard Deviation 9.6
22.5 Units on a scale
Standard Deviation 14.4

SECONDARY outcome

Timeframe: 240 minutes

Patients were equipped with a morphine PCA (patient controlled analgesia) for 24 hours after surgery. So they could administrate morphine intravenously by pressing a button. The sum of morphine was registered as " cumulated opioid consumption (milligram)

Outcome measures

Outcome measures
Measure
Pregabalin
n=22 Participants
Placebo
n=24 Participants
Morphine (Opioid) Consumption Cumulated
7.3 mg
Standard Deviation 6.3
16.0 mg
Standard Deviation 13.2

Adverse Events

Pregabalin

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ulrich J Spreng

Baerum Hospital

Phone: 004798499184

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place